Pulmonext 5Mg Tablet
Pulmonext 5Mg Tablet is a medication used to treat pulmonary hypertension in patients of WHO class II or WHO class III. It is an endothelin receptor antagonist that blocks certain substances present in the lungs, which in turn helps decrease the blood pressure inside the lungs.
You should refrain from using Pulmonext 5Mg Tablet if have any liver problems or lung problems, are allergic to any medicine, are pregnant, plan on becoming pregnant, or breastfeeding. You should also consult your doctor before taking Pulmonext 5Mg Tablet if you have history of heart failure, anemia, fluid retention problem, alcohol dependency or taking any medicines or supplements.
There are very few reported side effects of Pulmonext 5Mg Tablet. These include stuffy nose, irritation in nose or throat and flushing. You should see a doctor as soon as possible if any of these persist for prolonged duration.
Pulmonext 5Mg Tablet is available only as tablets to be taken orally. You can have them with or without food but you should consult your doctor regarding the appropiate dosage.
Is It safe with alcohol?Tadalafil can lower blood pressure, and combining it with alcohol may further increase this effect.
Are there any pregnancy warnings?Endobloc t kit is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
Are there any breast-feeding warnings?Endobloc t kit is probably unsafe to use during breastfeeding. Please consult your doctor.
Is it safe to drive while on this medicine?Caution is advised when driving or operating machinery.
It may cause dizziness. Exercise caution if you have to drive or operate a machinery.
Does this affect kidney function?No dose adjustment is needed for patients with the mild to moderate renal disease. Not advisable in patients with the severe renal disease.
Does this affect liver function?No dose adjustment is needed for patients with the mild to moderate liver disease. Dose adjustment is required in patients with severe liver disease.
This medication behaves as a potent selective endothelin type A receptor antagonist. Endothelin is a peptide synthesized within the vascular smooth muscle as well as endothelium and are acted upon by endothelin-1 which is an endogenous chain of amino acids connected by the amine bonds. Thus the medication antagonizes the action of endothelin and inhibit the constriction of blood vessels and reduces the blood pressure.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.